David Horst

13.1k total citations · 3 hit papers
170 papers, 6.1k citations indexed

About

David Horst is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, David Horst has authored 170 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 63 papers in Molecular Biology and 41 papers in Cancer Research. Recurrent topics in David Horst's work include Genetic factors in colorectal cancer (28 papers), Cancer Cells and Metastasis (27 papers) and Cancer Genomics and Diagnostics (21 papers). David Horst is often cited by papers focused on Genetic factors in colorectal cancer (28 papers), Cancer Cells and Metastasis (27 papers) and Cancer Genomics and Diagnostics (21 papers). David Horst collaborates with scholars based in Germany, United States and Austria. David Horst's co-authors include Thomas Kirchner, Andreas Jung, Heiko Hermeking, Lydia Kriegl, Matjaž Rokavec, Jutta Engel, Florian R. Greten, Markus Kaller, René Jackstadt and Jens Neumann and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Horst

153 papers receiving 6.0k citations

Hit Papers

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated c... 2014 2026 2018 2022 2014 2022 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
    2014 626 citations Matjaž Rokavec, René Jackstadt et al. profile →
  2. Targeting non-coding RNAs to overcome cancer therapy resistance
    2022 268 citations Mihnea P. Dragomir, David Horst et al. profile →
  3. Causes of death and comorbidities in hospitalized patients with COVID-19
    2021 251 citations Jana Ihlow, Philip Bischoff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Horst Germany 39 3.0k 2.5k 1.8k 816 694 170 6.1k
Amit Maity United States 45 3.4k 1.1× 2.7k 1.1× 1.9k 1.0× 1.2k 1.5× 1.0k 1.5× 153 7.2k
Luigi Marchionni United States 41 2.7k 0.9× 1.6k 0.6× 1.4k 0.8× 933 1.1× 595 0.9× 136 5.1k
Muh‐Hwa Yang Taiwan 48 4.0k 1.3× 2.9k 1.2× 2.2k 1.2× 990 1.2× 837 1.2× 164 7.6k
Jian Huang China 47 3.1k 1.0× 2.3k 0.9× 2.0k 1.1× 765 0.9× 1.8k 2.6× 242 7.0k
Ding Ma China 37 2.8k 0.9× 1.7k 0.7× 1.9k 1.1× 1.0k 1.2× 771 1.1× 202 5.7k
Jian Ma China 41 3.7k 1.2× 1.8k 0.7× 2.1k 1.2× 576 0.7× 1.5k 2.2× 126 6.1k
Jen Jen Yeh United States 39 3.2k 1.1× 3.2k 1.3× 1.7k 0.9× 933 1.1× 651 0.9× 110 6.5k
Vivian Wai Yan Lui Hong Kong 40 3.5k 1.2× 2.5k 1.0× 1.7k 0.9× 1.1k 1.4× 880 1.3× 112 6.9k
Peter A. van Dam Belgium 49 2.8k 0.9× 3.6k 1.5× 2.5k 1.3× 1.0k 1.2× 891 1.3× 186 7.2k
Catherine O′Brien Canada 27 3.9k 1.3× 4.0k 1.6× 1.8k 1.0× 899 1.1× 961 1.4× 79 7.6k

Countries citing papers authored by David Horst

Since Specialization
Citations

This map shows the geographic impact of David Horst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Horst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Horst more than expected).

Fields of papers citing papers by David Horst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Horst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Horst. The network helps show where David Horst may publish in the future.

Co-authorship network of co-authors of David Horst

This figure shows the co-authorship network connecting the top 25 collaborators of David Horst. A scholar is included among the top collaborators of David Horst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Horst. David Horst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoffmann, Inga, Jalid Sehouli, Gerald Niedobitek, et al.. (2025). Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer. Clinical Cancer Research. 31(18). 3956–3969.
3.
Eich, Marie‐Lisa, Georg Hilfenhaus, Bernhard Ralla, et al.. (2024). Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer. Urology Case Reports. 57. 102879–102879.
4.
5.
Stahler, Arndt, Christine Sers, Soulafa Mamlouk, et al.. (2024). Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212). Clinical Cancer Research. 30(7). 1256–1263. 9 indexed citations
6.
Blanc, Eric, Stefan Peidli, Philip Bischoff, et al.. (2024). High‐confidence calling of normal epithelial cells allows identification of a novel stem‐like cell state in the colorectal cancer microenvironment. International Journal of Cancer. 155(9). 1655–1669. 1 indexed citations
7.
Shmatko, Artem, Alexander Arnold, David Horst, et al.. (2024). Teacher-student collaborated multiple instance learning for pan-cancer PDL1 expression prediction from histopathology slides. Nature Communications. 15(1). 3063–3063. 10 indexed citations
8.
Steffen, Claudius, Simon Schallenberg, Mihnea P. Dragomir, et al.. (2023). Spatial heterogeneity of tumor cells and the tissue microenvironment in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 137(4). 379–390. 2 indexed citations
9.
Ihlow, Jana, Inga Hoffmann, Philip Bischoff, et al.. (2022). Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers. 14(19). 4620–4620. 8 indexed citations
10.
Bischoff, Philip, Alexandra Trinks, Benedikt Obermayer, et al.. (2022). The single‐cell transcriptional landscape of lung carcinoid tumors. International Journal of Cancer. 150(12). 2058–2071. 18 indexed citations
11.
Bassiouni, Mohamed, et al.. (2022). The Relationship between the M1/M2 Macrophage Polarization and the Degree of Ossicular Erosion in Human Acquired Cholesteatoma: An Immunohistochemical Study. Journal of Clinical Medicine. 11(16). 4826–4826. 7 indexed citations
12.
Kulbe, Hagen, Oliver Klein, Eliane T. Taube, et al.. (2020). Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging. Cancers. 12(8). 2000–2000. 13 indexed citations
13.
Kaller, Markus, Eva Marina Schmidt, Cristina Blaj, et al.. (2018). PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer. Clinical Cancer Research. 24(8). 1974–1986. 40 indexed citations
14.
Rokavec, Matjaž, David Horst, & Heiko Hermeking. (2017). Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis. Cancer Research. 77(8). 1854–1867. 79 indexed citations
15.
Blaj, Cristina, Eva Marina Schmidt, Heiko Hermeking, et al.. (2017). Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations. Cancer Research. 77(7). 1763–1774. 57 indexed citations
16.
Cejas, Paloma, Alessia Cavazza, Vı́ctor Moreno, et al.. (2016). Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype. Cancer Research. 77(3). 766–779. 19 indexed citations
17.
Blaj, Cristina, Eva Marina Schmidt, Thomas Fröhlich, et al.. (2016). ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer. Clinical Cancer Research. 23(11). 2769–2780. 27 indexed citations
18.
Horst, David, et al.. (2012). Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling. Cancer Research. 72(6). 1547–1556. 94 indexed citations
19.
Siemens, Helge, Jens Neumann, René Jackstadt, et al.. (2012). Detection of miR-34a Promoter Methylation in Combination with Elevated Expression of c-Met and β-Catenin Predicts Distant Metastasis of Colon Cancer. Clinical Cancer Research. 19(3). 710–720. 125 indexed citations
20.
Horst, David, et al.. (2011). Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer. Clinical Cancer Research. 18(4). 956–968. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amit Maity Breakdown of academic impact, for papers by Luigi Marchionni Breakdown of academic impact, for papers by Muh‐Hwa Yang Breakdown of academic impact, for papers by Jian Huang Breakdown of academic impact, for papers by Ding Ma Breakdown of academic impact, for papers by Jian Ma Breakdown of academic impact, for papers by Jen Jen Yeh Breakdown of academic impact, for papers by Vivian Wai Yan Lui Breakdown of academic impact, for papers by Peter A. van Dam Breakdown of academic impact, for papers by Catherine O′Brien
Rankless by CCL
2026